Advanced glycation end products and antioxidant status in nondiabetic and streptozotocin induced diabetic rats: Effects of copper treatment

BioMetals

Volumn 23, Issue 1, 2010, Pages 43-49

  Civelek, S ^a   Gelisgen R ^a   Andican, G ^a   Seven, A ^a   Kucuk S H ^a   Ozdogan M ^a   Burcak G ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Advanced glycation end products; Copper; Diabetes mellitus; Glycation; STZ

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTIOXIDANT; COPPER; COPPER CHLORIDE; GLUCOSE; GLUTATHIONE; GLYCOSYLATED HEMOGLOBIN; STREPTOZOCIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CELL LEVEL; CHELATION THERAPY; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; ERYTHROCYTE; EXPERIMENTAL MODEL; GLYCEMIC CONTROL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID PEROXIDATION; MALE; NONHUMAN; ONLINE SYSTEM; RAT; SPECTROFLUOROMETRY; SPECTROPHOTOMETRY; STREPTOZOCIN DIABETES;

RATTUS;

EID: 77949425198     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10534-009-9265-9     Document Type: Article

References (22)

1. Abou-Seif MA, Youssef AA (2004) Evaluation of some biochemical changes in diabetic patients. Clin Chim Acta 346:161-170.
2. Alcock NW (1987) Copper. In: Pesce AJ, Kaplan LA (eds) Methods in clinical chemistry. Mosby, St Louis, pp 527- 538.
3. Argirova MD, Ortwerth BJ (2003) Activation of protein-bound copper ions during early glycation: study on two proteins. Arch Biochem Biophys 420:176-184.
4. Beutler E, Durgn O, Kelly BM (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 51:882-888.
5. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52:302-310.
6. Committee on Care and Use of Laboratory Animals (1985) Guide for the care and use of laboratory animals. Institute of Laboratory Animal Resources, National Research Council, Washington.
7. Cooper GJ, Chan YK, Dissanayake AM et al (2005) Demonstration of a hyperglycemia-driven pathogenic abnormality of copper homeostasis in diabetes and its reversibility by selective chelation: quantitative comparisons between the biology of copper and eight other nutritionally essential elements in normal and diabetic individuals. Diabetes 54:1468-1476.
8. Eaton JW, Qian M (2002) Interactions of copper with glycated proteins: possible involvement in the etiology of diabetic neuropathy. Mol Cell Biochem 234-235:135-142.
9. Eizirik DL, Flodström M, Karlsen AE et al (1996) The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia 39:875-890.
10. Forbes JM, Yee LT, Thallas V et al (2004) Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. Diabetes 53:1813-1823.
11. Galhardi CM, Diniz YS, FaineLA et al (2004) Toxicity of copper intake: lipid profile, oxidative stress and susceptibility to renal dysfunction. Food Chem Toxicol 42:2053-2060.
12. Hussein OA, Gefen Y, Zidan JM et al (2007) LDL oxidation is associated with increased blood hemoglobin A1c levels in diabetic patients. Clin Chim Acta 377:114-118.
13. Islam KN, Takahashi M, Higashiyama S et al (1995) Fragmentation of ceruloplasmin following nonenzymatic glycation reaction. J Biochem 118:1054-1060.
14. Lin J (1996) The association between copper ions and peroxidative reaction in diabetic cataract. Nippon Ganka Gakkai Zasshi 100:672-679.
15. Linder MC (1991) Biochemistry of copper. Plenum, New York.
16. Miller NJ, Rice-Evans C, Davies MJ et al (1993) A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 84:407-412.
17. Selvaraj N, Bobby Z, Das AK et al (2002) An evaluation of level of oxidative stress and protein glycation in nondiabetic undialyzed chronic renal failure patients. Clin Chim Acta 324:45-50.
18. Selvaraj N, Bobby Z, Koner BC et al (2005) Reassessing the increased glycation of hemoglobin in nondiabetic chronic renal failure patients: a hypothesis on the role of lipid peroxides. Clin Chim Acta 360:108-113.
19. Shimatzu Corp. (1998) Atomic absorption spectrophotometry cookbook, Sect 1-4. Shimatzu Corp., Kyoto, p 10.
20. Sitasawad S, Deshpande M, Katdare M et al (2001) Beneficial effect of supplementation with copper sulfate on STZ-diabetic mice (IDDM). Diabetes Res Clin Pract 52:77-84.
21. Wrobel K, Wrobel K, Garay-Sevilla ME et al (1997) Novel analytical approach to monitoring advanced glycosylation end products in human serum with on-line spectrophotometric and spectrofluorometric detection in a flow system. Clin Chem 43:1563-1569.
22. Yoshida K, Hirokawa J, Tagami S et al (1995) Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia 38:201-210.